Literature DB >> 12113331

Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting.

M Eriksson1, R Bennet, M Rotzén-Ostlund, M von Sydow, B Zweygberg Wirgart.   

Abstract

UNLABELLED: The aim of this study was to make a population-based estimate of the risk of hospitalization and complications during virologically confirmed respiratory syncytial virus (RSV) infection in relation to established risk factors, and an estimation of additional risk factors and outcome as seen in a tertiary care referral centre. During a period of 12 y, all children with virologically confirmed RSV infection were included. Recorded complications were: admission to the intensive care unit, mechanical ventilation, death and later hospitalization for wheezing. In total, 1503 cases were identified, 1354 of which originated from the population defined by the catchment area. There was a biannual seasonal variation with late small outbreaks alternating with early large ones. The hospitalization rates for infants without risk factors were 0.8 and 1.4% during the 2 epidemic types. They were 1.6-3.2% for infants born preterm (<33 gestational wk), 2.9-7.0% for children under 2 y old with chronic lung disease of prematurity and 2.8-6.4% for infants with congenital heart disease. The presence of siblings in the family more than doubled the risk of hospitalization. Later hospitalization for wheezing occurred in 8.4 and 4.9% of children without risk factors over and under the age of 2 mo, respectively (p < 0.001).
CONCLUSION: This study found lower population rates of hospitalization and complications than have previously been reported. The seasonal variation and the presence of siblings in the home influenced these rates by factors of 2.

Entities:  

Mesh:

Year:  2002        PMID: 12113331     DOI: 10.1080/080352502753711740

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  26 in total

1.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

2.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

3.  The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model.

Authors:  Ashleigh A McGirr; Kevin L Schwartz; Upton Allen; Melinda Solomon; Beate Sander
Journal:  Hum Vaccin Immunother       Date:  2016-10-21       Impact factor: 3.452

4.  Human metapneumovirus infections--biannual epidemics and clinical findings in children in the region of Basel, Switzerland.

Authors:  Ulrich Heininger; Anna Tina Kruker; Jan Bonhoeffer; Urs B Schaad
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

5.  Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease.

Authors:  A Duppenthaler; R A Ammann; M Gorgievski-Hrisoho; J-P Pfammatter; C Aebi
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

Review 6.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; D James Nokes; Bradford D Gessner; Mukesh Dherani; Shabir A Madhi; Rosalyn J Singleton; Katherine L O'Brien; Anna Roca; Peter F Wright; Nigel Bruce; Aruna Chandran; Evropi Theodoratou; Agustinus Sutanto; Endang R Sedyaningsih; Mwanajuma Ngama; Patrick K Munywoki; Cissy Kartasasmita; Eric A F Simões; Igor Rudan; Martin W Weber; Harry Campbell
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

7.  Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  P S McNamara; P Ritson; A Selby; C A Hart; R L Smyth
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

8.  Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study).

Authors:  Johannes Forster; Gabriele Ihorst; Christian H L Rieger; Volker Stephan; Hans-Dieter Frank; Heidrum Gurth; Reinhard Berner; Angela Rohwedder; Hermann Werchau; Martin Schumacher; Theodore Tsai; Gudula Petersen
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

9.  Influenza A and respiratory syncytial virus hospital burden in young children in East London.

Authors:  E K Ajayi-Obe; P G Coen; R Handa; K Hawrami; C Aitken; E D G McIntosh; R Booy
Journal:  Epidemiol Infect       Date:  2007-09-28       Impact factor: 2.451

10.  Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.

Authors:  Beth K Thielen; Erica Bye; Xiong Wang; Stacene Maroushek; Hannah Friedlander; Sarah Bistodeau; Jaime Christensen; Erik Reisdorf; Meghan H Shilts; Karen Martin; Kathryn Como-Sabetti; Anna K Strain; Patricia Ferrieri; Ruth Lynfield
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.